Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
January 5th, 2023
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
December 14th, 2022
APDN to Report FY’22 Q4 and Year End Financial Results
December 12th, 2022
APDN to Establish N. America’s 1st Enzymatic Large-Scale cGMP DNA Manufacturing Capacity in NY
October 24th, 2022
APDN Receives Largest Single Purchase Order for LinearDNA To Date
October 10th, 2022
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30th, 2022
APDN, Cornell University College of Veterinary Medicine Research Collaboration
September 8th, 2022
APDN to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 7th, 2022
Applied DNA Launches Monkeypox Testing Service
September 6th, 2022